Jefferies Group's RARE Position Overview
Jefferies Group (via Jefferies Financial Group Inc.) currently holds 929,626 shares of Ultragenyx Pharmaceutical Inc. (RARE) worth $31.04 M, representing 0.20% of the portfolio. First purchased in 2024-Q2, this short-term holding has been held for 5 quarters.
Based on 13F filings, Jefferies Group has maintained this position in RARE for several quarters, showing initial confidence in the investment. Largest addition occurred in Q2 2026, adding 914,138 shares. Largest reduction occurred in Q1 2026, reducing 461,604 shares.
Analysis based on 13F filings available since 2013 Q2
Jefferies Group's Ultragenyx Pharmaceutical (RARE) Holding Value Over Time
Track share changes against reported price movement
Quarterly Ultragenyx Pharmaceutical (RARE) Trades by Jefferies Group
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +914,138 | Add 5902.23% | 929,626 | $33.39 |
| Q1 2026 | -461,604 | Reduce 96.75% | 15,488 | $20.95 |
| Q4 2025 | +477,092 | New Buy | 477,092 | $23.00 |
| Q3 2024 | -10,250 | Sold Out | 0 | $0.00 |
| Q2 2024 | +10,250 | New Buy | 10,250 | $41.10 |
Jefferies Group's Ultragenyx Pharmaceutical Investment FAQs
Jefferies Group first purchased Ultragenyx Pharmaceutical Inc. (RARE) in Q2 2024, acquiring 10,250 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jefferies Group has held Ultragenyx Pharmaceutical Inc. (RARE) for 5 quarters since Q2 2024.
Jefferies Group's largest addition to Ultragenyx Pharmaceutical Inc. (RARE) was in Q2 2026, adding 929,626 shares worth $31.04 M.
According to the latest 13F filing for Q2 2026, Jefferies Group's firm, Jefferies Financial Group Inc., owns 929,626 shares of Ultragenyx Pharmaceutical Inc. (RARE), valued at approximately $31.04 M.
As of the Q2 2026 filing, Ultragenyx Pharmaceutical Inc. (RARE) represents approximately 0.20% of Jefferies Group's publicly disclosed stock portfolio, making it one of their key holdings.
Jefferies Group's peak holding in Ultragenyx Pharmaceutical Inc. (RARE) was 929,626 shares, as reported at the end of Q2 2026.